Cargando…

Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder

OBJECTIVES: Ecological momentary sampling in BD research requires brief symptom measures with low cognitive demands to maximize data collection across the range of BD symptomatology. We developed the BD S(x) cognizant of the challenges inherent in scale development with low prevalence populations an...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Rourke, Norm, Sixsmith, Andrew, King, David B., Yaghoubi-Shahir, Hamed, Canham, Sarah L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771673/
https://www.ncbi.nlm.nih.gov/pubmed/26928123
http://dx.doi.org/10.1186/s40345-016-0048-2
_version_ 1782418420569997312
author O’Rourke, Norm
Sixsmith, Andrew
King, David B.
Yaghoubi-Shahir, Hamed
Canham, Sarah L.
author_facet O’Rourke, Norm
Sixsmith, Andrew
King, David B.
Yaghoubi-Shahir, Hamed
Canham, Sarah L.
author_sort O’Rourke, Norm
collection PubMed
description OBJECTIVES: Ecological momentary sampling in BD research requires brief symptom measures with low cognitive demands to maximize data collection across the range of BD symptomatology. We developed the BD S(x) cognizant of the challenges inherent in scale development with low prevalence populations and the limitations of existing measures (e.g., over-reliance on patients in acute states recruited from psychiatric settings). In order to be generalizable across the full spectrum of the illness, we also included those currently euthymic and those who avoid clinical contact. METHODS: We recruited a global sample of 1010 adults with BD over 19 days using socio-demographically targeted, social media advertising and online data collection. At follow-up, 428 participants provided responses 67 days later on average. This enabled us to develop the BD S(x) and replicate initial findings across multiple samples over time. RESULTS: Both exploratory and confirmatory factor analyses support a 4-factor BD S(x) model. Goodness of fit indices indicate good model fit across samples and over time. We labeled these factors: elation/loss of insight, affrontive symptoms of mania, cognitive/depressive, and somatic/depressive symptoms. Affrontive symptoms correlate positively with cognitive and somatic depression factors, which may suggest mixed-state symptom clusters in accord with DSM 5. CONCLUSIONS: Responses to the BD S(x) reliably measure both depressive and hypo/manic symptoms. Temporal invariance analyses indicate that the 4-factor structure is consistent over time. Future research  should compare BD S(x) responses to clinical diagnoses of hypo/mania and major depressive episodes.
format Online
Article
Text
id pubmed-4771673
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47716732016-03-29 Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder O’Rourke, Norm Sixsmith, Andrew King, David B. Yaghoubi-Shahir, Hamed Canham, Sarah L. Int J Bipolar Disord Research OBJECTIVES: Ecological momentary sampling in BD research requires brief symptom measures with low cognitive demands to maximize data collection across the range of BD symptomatology. We developed the BD S(x) cognizant of the challenges inherent in scale development with low prevalence populations and the limitations of existing measures (e.g., over-reliance on patients in acute states recruited from psychiatric settings). In order to be generalizable across the full spectrum of the illness, we also included those currently euthymic and those who avoid clinical contact. METHODS: We recruited a global sample of 1010 adults with BD over 19 days using socio-demographically targeted, social media advertising and online data collection. At follow-up, 428 participants provided responses 67 days later on average. This enabled us to develop the BD S(x) and replicate initial findings across multiple samples over time. RESULTS: Both exploratory and confirmatory factor analyses support a 4-factor BD S(x) model. Goodness of fit indices indicate good model fit across samples and over time. We labeled these factors: elation/loss of insight, affrontive symptoms of mania, cognitive/depressive, and somatic/depressive symptoms. Affrontive symptoms correlate positively with cognitive and somatic depression factors, which may suggest mixed-state symptom clusters in accord with DSM 5. CONCLUSIONS: Responses to the BD S(x) reliably measure both depressive and hypo/manic symptoms. Temporal invariance analyses indicate that the 4-factor structure is consistent over time. Future research  should compare BD S(x) responses to clinical diagnoses of hypo/mania and major depressive episodes. Springer Berlin Heidelberg 2016-03-01 /pmc/articles/PMC4771673/ /pubmed/26928123 http://dx.doi.org/10.1186/s40345-016-0048-2 Text en © O’Rourke et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
O’Rourke, Norm
Sixsmith, Andrew
King, David B.
Yaghoubi-Shahir, Hamed
Canham, Sarah L.
Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title_full Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title_fullStr Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title_full_unstemmed Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title_short Development and validation of the BD S(X): a brief measure of mood and symptom variability for use with adults with bipolar disorder
title_sort development and validation of the bd s(x): a brief measure of mood and symptom variability for use with adults with bipolar disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771673/
https://www.ncbi.nlm.nih.gov/pubmed/26928123
http://dx.doi.org/10.1186/s40345-016-0048-2
work_keys_str_mv AT orourkenorm developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder
AT sixsmithandrew developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder
AT kingdavidb developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder
AT yaghoubishahirhamed developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder
AT canhamsarahl developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder
AT developmentandvalidationofthebdsxabriefmeasureofmoodandsymptomvariabilityforusewithadultswithbipolardisorder